Sort by
Refine Your Search
-
°C, is applied in combination with radiotherapy and/or chemotherapy to improve clinical outcome. In recent years, the ability of hyperthermia to dramatically enhance tumour control rates and even
-
goal. About the research project Hyperthermia therapy, i.e heating of tumour tissue in the range of 40–44°C, is applied in combination with radiotherapy and/or chemotherapy to improve clinical outcome
-
therapy combined with standard treatment can extend patient survival by 10–12 months. We have also demonstrated that radiotherapy induces reactivation of HCMV in approximately 50% of patients, placing
-
patient outcome. Importantly, our clinical studies show that antiviral therapy, when combined with standard treatment, can extend patient survival by 10–12 months. We have further shown that radiotherapy
-
studies show that antiviral therapy combined with standard treatment provides a significant survival benefit, and that radiotherapy induces viral reactivation in a substantial fraction of patients, placing